fda warning compounding semaglutide september 2025 Compounded "semaglutide" is not FDA-approved Novo Nordisk Calls for FDA

On June 27, 2025, Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing, manufacturing, and commercializing high-quality medicines for oncology, autoimmune, cardiovascular, and metabolic diseases, announced that China's National Medical Products Administration (NMPA) approved Mazdutide, the worlds first dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in Chinese adults with overweight or obesity

As receptor agonists, GLP-1 medications mimic the natural GLP-1 hormone

Point #6

If you cant keep a morning fasting routine Foundayo is the more flexible option, with no empty stomach, no water cap, and no 30-minute wait

Can I get GLP-1 medications online without seeing a doctor in person